Target intelligence / Profile preview

Quaking, KH domain-containing RNA-binding protein (QKI)

Target
QKI
Molecular classification
RNA-binding protein, Signal transduction and activation of RNA (STAR) family, transcription coactivator
01

Overview

Quaking (QKI) is a KH domain-containing RNA-binding protein and member of the STAR family, with key roles in regulating RNA metabolism, including pre-mRNA splicing, stability, export, and translation. It is essential for normal development of the nervous system—particularly for oligodendrocyte differentiation and myelination—by controlling RNA homeostasis at transcriptional and post-transcriptional levels. QKI functions as a tumor suppressor and regulates cellular processes such as angiogenesis, apoptosis, and cell differentiation. QKI interacts extensively with microRNAs, long non-coding RNAs, and circular RNAs, forming intricate regulatory networks relevant in cancer, neurological, and developmental diseases. The MYB-QKI fusion protein is specifically implicated in certain gliomas. QKI is emerging as a valuable biomarker for diagnosing and monitoring several cancers and CNS disorders[1][2].

Other names
QKI, KH domain-containing RNA-binding proteinQKIHKQHqkHqkIQK3Protein quakingQKQK1hqkIQKI/LOC100132735 fusionRNA-binding protein HQKhomolog of mouse quaking QKIquaking homologKH domain RNA binding
02

Mechanism of action

Indirect suppression of MYB-QKI fusion (glioma) via CDK7 or BET inhibition; potential role in modulating resistance to chemotherapy and targeted drugs in cancer[1].

03

Biological functions

MyelinizationOligodendrocyte differentiationPre-mRNA splicingmRNA exportmRNA stability and translationRNA homeostasis (including circular RNAs, microRNAs, long non-coding RNAs)Angiogenesis regulationApoptosisCholesterol biosynthesis
04

Disease associations

Cancer (glioblastoma, lung, gastric, prostate, others)Neuropsychiatric disorders (schizophrenia, depression, Alzheimer’s, ataxia)Neurodegenerative diseases (frontotemporal dementia, amyotrophic lateral sclerosis)Angiocentric gliomaDevelopmental abnormalities (myelin sheath, congenital diaphragmatic hernia lung)Cardiovascular disease (myofibril development)
05

Safety considerations

Therapeutic challenges include lack of direct inhibitorsInvolvement in essential CNS developmental processes (risk for neurotoxicity)Role in mRNA and non-coding RNA networks increases risk for off-target effectsPromoter methylation leading to QKI silencing has pathological significance
06

Interacting drugs

No direct, clinically approved drugs targeting QKI are reported

2 more in the full profile.

07

Biomarkers

QKI as a tumor suppressor and biomarker for cancer prognosis (particularly in gliomas and other solid tumors)MYB-QKI fusion as a diagnostic biomarker for angiogenic glioma

Beyond the preview

Go deeper on Quaking, KH domain-containing RNA-binding protein (QKI).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Quaking, KH domain-containing RNA-binding protein (QKI).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call